Demo Sign up Log In

Regeneron Pharmaceuticals (REGN)

Accounts Payable

$1.16B

Quarterly · Period ending: Jun 30, 2026 · USD

REGN Accounts Payable

Latest reported$1.16Bperiod endingJun 30, 2026

Latest reported$1.16Bperiod endingJun 30, 2026

REGN Quarterly Accounts Payable ($0.00 → $1.16B)

Quarterly accounts payable

High-resolution chart · PNG

REGN accounts payable history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Accounts Payable — Quarterly (USD)
Period ending	Accounts Payable (USD)
Jun 30, 2001	8,304,000
Mar 31, 2001	9,404,000
Dec 31, 2000	9,446,000
Sep 30, 2000	8,021,000
Jun 30, 2000	7,637,000
Mar 31, 2000	6,921,000
Dec 31, 1999	6,600,000
Sep 30, 1999	4,500,000
Jun 30, 1999	4,900,000
Mar 31, 1999	6,000,000
Dec 31, 1998	5,600,000
Sep 30, 1998	4,400,000
Jun 30, 1998	5,100,000
Mar 31, 1998	3,700,000
Dec 31, 1997	4,700,000
Sep 30, 1997	4,100,000
Jun 30, 1997	5,100,000
Mar 31, 1997	3,400,000
Dec 31, 1996	4,400,000
Sep 30, 1996	4,200,000
Jun 30, 1996	4,200,000
Mar 31, 1996	4,300,000
Dec 31, 1995	6,300,000
Sep 30, 1995	4,300,000
Jun 30, 1995	4,600,000
Mar 31, 1995	3,700,000
Dec 31, 1994	5,000,000
Sep 30, 1994	4,200,000
Jun 30, 1994	6,400,000
Mar 31, 1994	6,000,000
Dec 31, 1993	10,300,000
Sep 30, 1993	6,700,000
Jun 30, 1993	5,200,000
Mar 31, 1993	3,000,000
Dec 31, 1992	2,500,000
Sep 30, 1992	0
Jun 30, 1992	1,900,000
Mar 31, 1992	1,900,000
Dec 31, 1991	1,600,000
Sep 30, 1991	500,000
Jun 30, 1991	800,000
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.